eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
4/2015
vol. 66
 
Share:
Share:
more
 
 
abstract:
Original paper

Androgen receptor in male breast cancer

Beata Sas-Korczynska
,
Agnieszka Adamczyk
,
Joanna Niemiec
,
Agnieszka Harazin-Lechowska
,
Aleksandra Ambicka
,
Jerzy Jakubowicz

Pol J Pathol 2015; 66 (4): 347-352
Online publish date: 2016/02/05
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
We present the androgen receptor (AR) status in 32 breast cancers diagnosed in male patients. Androgen receptor expression was found in 62.5% tumors and it was more frequent (85% of cases) in estrogen-positive tumours. The analyses of its impact on treatment results showed that AR immmunopositivity is a prognostic factor for overall survival, and AR immunonegativity is also correlated with worse prognosis (distant metastases developed more frequently and earlier).
keywords:

androgen receptor, male breast cancer

FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe